Skip to content Skip to footer
The development of cell and gene therapies has the potential to revolutionize the treatment and provide a potential cure for various diseases. However, despite their transformative potential, there is a significant gap in patient access, with only a fraction of eligible patients currently receiving these life-changing therapies. To address this issue, it is crucial to dispel misconceptions and build unique and persuasive value narratives that promote wider adoption and understanding of these innovative therapies with a diverse group of stakeholders. This article explores the importance of removing misconceptions and changing the narrative surrounding cell and gene therapies.
Tip 1: Addressing Misconceptions and Highlighting Manageable Side Effects

One of the major misconceptions surrounding cell and gene therapies, such as CAR-T, is the belief that they have severe and uncontrollable side effects. However, it is essential to emphasize that while these therapies can have side effects, they are generally manageable and can be effectively addressed by healthcare professionals. By providing accurate information and sharing success stories, we can help alleviate concerns and foster a better understanding of the safety and tolerability of these therapies. Patients and their families need to know that the potential benefits of cell and gene therapies far outweigh the risks, and adverse events are often outweighed by the potential for a one-time chance at a cure.

Tip 2: Reinventing Medicine and the Value Story

Cell and gene therapies represent a paradigm shift in medicine. They offer the potential for long-term, if not permanent, treatment and even cures for patients. It is important to highlight that these therapies are not simply costly interventions but investments in a patient’s future. By comparing the cost of multiple doses over several years to the cost of a one-time cell and gene therapy treatment, we can emphasize the cost-effectiveness and value of these therapies in the long run. By changing the narrative from a short-term cost burden to a long-term investment in patient health, we can help stakeholders recognize the unique value proposition that cell and gene therapies offer.

Tip 3: Explain the Science and Innovation

Cell and gene therapies involve complex scientific concepts and cutting-edge technology. It is essential to find new and vibrant ways to explain the science behind these therapies, building trust and excitement among patients, healthcare professionals, payers, and the general public. By breaking down the complexities and presenting the innovations in a digestible manner, we can enhance understanding and acceptance of these groundbreaking therapies.

Tip 4: Use Data to Support the Story

In crafting value narratives, the use of data is crucial. Clinical and economic evidence can validate the benefits and cost-effectiveness of cell and gene therapies. Generating robust cost-effectiveness data ahead of therapy launches helps sustain the value narrative and address potential concerns regarding long-term affordability. Identifying and filling evidence gaps while outlining future research needs demonstrates a commitment to improving patient outcomes and supports the therapy’s value proposition.

Tip 5: Understand Audience Needs

Tailoring the value narrative to the specific needs and interests of different stakeholders is paramount. Patients, physicians, researchers, regulators, payers, investors, and the general public each have unique perspectives. When communicating with payers, it is crucial to emphasize how the therapy alleviates clinical and cost burdens within the healthcare system, ultimately providing value to patients. Addressing concerns and clearly articulating the benefits of cell and gene therapies fosters a more receptive environment for their adoption.

Tip 6: Craft a Compelling Narrative

A compelling value narrative starts by addressing the problem the innovation solves. Clearly describing the benefits of the therapy and connecting it to the people it helps creates an emotional connection between the innovation and the audience. Storytelling is a powerful tool in conveying the transformative potential of cell and gene therapies. By sharing narratives, anecdotes, and personal experiences, we can humanize these therapies and engage stakeholders on a deeper level.

Tip 7: Leverage the Power of Visual Aids

Visual aids such as charts, graphs, infographics, videos, and animations can simplify complex scientific concepts and data, making them more accessible to a wide audience. By incorporating visual elements into value narratives, we can enhance understanding and capture attention, effectively conveying the value and potential of cell and gene therapies.


In conclusion, cell and gene therapies have the potential to revolutionize disease treatment and offer a cure, but the current gap in patient access calls for dispelling misconceptions and changing the narrative. It is important for all stakeholders to work together in this endeavor, as no single company can achieve it alone. By addressing manageable side effects, highlighting long-term value, and collaborating across the healthcare ecosystem, we can build persuasive narratives and overcome barriers to wider adoption. Explaining the science, using data, understanding audience needs, crafting compelling stories, and leveraging visual aids are crucial strategies. Together, we can bridge the access gap and integrate these therapies into standard medical practice.

Do you need help with building the value narrative for your innovation? Don’t hesitate to contact us.

Leave a comment